Target Name: LOC105371649
NCBI ID: G105371649
Review Report on LOC105371649 Target / Biomarker Content of Review Report on LOC105371649 Target / Biomarker
LOC105371649
Other Name(s): uncharacterized LOC105371649 | Uncharacterized LOC105371649

LOC105371649: A Potential Drug Target and Biomarker

LOC105371649 is a protein that has not yet been characterized, but it is possible that it could be a drug target or biomarker. The protein is a potential target for small molecule inhibitors because it has a unique structure that is involved in multiple cellular processes. This structure makes it a promising target for drugs that can inhibit the activity of the protein and potentially lead to the death of cancer cells.

The protein that LOC105371649 is a part of is called the B-cell receptor (BCR), which is a protein that is found on the surface of many different types of cells in the body. BCRs are involved in the process of cell growth, division, and signaling, and they are often used as drug targets because they can be targeted by small molecules. The BCR is made up of two parts: the constant region and the variable region. The constant region is the part of the protein that is always present, while the variable region is the part of the protein that is unique to each individual cell.

LOC105371649 is located in the variable region of the BCR, and it is involved in the process of cell signaling. Specifically, it is involved in the interaction between the BCR and the protein called tyrosine kinase, which is a type of enzyme that can cause changes in the structure and function of the BCR. This interaction between the BCR and tyrosine kinase is important for the function of the BCR, and it is possible that LOC105371649 could be a drug target because it is involved in this interaction.

One of the challenges in targeting LOC105371649 as a drug target is the fact that it is not yet clear exactly how it functions. This is because it is not yet possible to use many of the techniques that are commonly used to study the BCR and its interactions with other proteins. In order to understand how LOC105371649 works, researchers will need to use a variety of techniques, including biochemical assays, cell-based assays, and structural studies.

If LOC105371649 is found to be a drug target, it could be used to treat a variety of different diseases. For example, LOC105371649 is involved in the process of cell signaling, and so it could be used to treat conditions that are related to abnormal cell signaling, such as cancer, hypertension, and diabetes. Additionally, LOC105371649 may also be a useful biomarker for tracking the effectiveness of certain treatments. This is because if LOC105371649 is inhibited by a drug, the levels of the protein in cells may be able to be measured and used as a marker for the effectiveness of the treatment.

In conclusion, LOC105371649 is a protein that is still being studied and understood. While it is not yet clear exactly how it functions, it is possible that it could be a drug target or biomarker. If it is found to be a drug target, LOC105371649 could be used to treat a variety of different diseases, and it may also be a useful biomarker for tracking the effectiveness of certain treatments. Further research is needed to fully understand the role of LOC105371649 in the body and to develop effective treatments.

Protein Name: Uncharacterized LOC105371649

The "LOC105371649 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371649 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685